Skip to main content
LGVN logo

Longeveron Inc. (LGVN)

LGVNNASDAQHealthcareBiotechnology

$1.66Today:−$0.09 (−5.21%)1Y +203.33%

As of Nov 20, 2026 close

Market cap
$5.84M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.48$8.90
Volume (live)
-
Avg. volume (3M)
90.25K

Longeveron (LGVN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Longeveron reported total assets of $10.26M and total liabilities of $4.59M. Shareholders' equity was $5.67M, down 74.1% from $21.89M a year earlier. Total debt stood at $824.00K against $4.66M in cash and short-term investments, a net cash position of $3.84M. That puts debt-to-equity at 0.15, compared with 0.07 a year earlier.

Longeveron Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Longeveron Inc. (LGVN) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents4.6619.234.9510.5025.660.821.874.03
Short-Term Investments0.000.000.419.169.390.000.000.00
Cash & Short-Term Investments4.6619.235.3619.6635.040.821.874.03
Accounts Receivable0.100.080.110.220.060.420.450.00
Inventory0.000.000.000.000.000.000.000.00
Other Current Assets0.690.310.380.400.280.050.050.13
Total Current Assets5.4519.625.8520.2835.381.852.374.16
Non-Current Assets
Property, Plant & Equipment (Net)2.353.333.754.484.885.676.484.76
Long-Term Investments0.100.000.000.000.000.000.000.00
Intangible Assets2.292.402.292.412.331.551.481.35
Other Non-Current Assets0.180.200.190.240.180.180.250.25
Total Non-Current Assets4.815.936.237.137.397.398.216.36
Total Assets10.2625.5612.0827.4142.779.2410.5810.52
Current Liabilities
Accounts Payable0.420.100.641.750.651.591.151.21
Short-Term Debt0.660.620.590.560.540.140.490.00
Current Portion of Long-Term Debt-----0.14--
Accrued Liabilities2.971.822.150.651.331.54--
Deferred Revenue0.040.040.510.510.200.010.540.41
Other Current Liabilities2.971.822.151.401.331.540.300.25
Total Current Liabilities4.092.583.894.872.713.832.491.86
Non-Current Liabilities
Long-Term Debt0.170.821.452.042.610.313.650.00
Other Non-Current Liabilities0.330.270.000.000.000.000.001.84
Total Non-Current Liabilities0.501.091.452.042.613.453.651.84
Total Liabilities4.593.675.346.915.317.286.143.71
Stockholders' Equity
Common Stock0.020.010.000.020.022.060.007.11
Retained Earnings-132.31-109.61-84.98-62.77-43.940.000.000.00
Accumulated Other Comprehensive Income0.000.00-0.10-0.46-0.10-0.100.00-1.39
Additional Paid-in Capital137.96131.4891.8283.7181.470.004.450.00
Shares Outstanding2.291.490.250.212.09---
Total Stockholders' Equity5.6821.896.7420.5037.451.964.456.81
Total Liabilities & Equity10.2625.5612.0827.4142.779.2410.5810.52

Source: Company financial statements from annual and quarterly filings. Data as of Sep 30, 2026. Data sources and methodology

Frequently Asked Questions About Longeveron Balance Sheet

How much debt does Longeveron have?

Longeveron had total debt of $824.00K as of Dec 31, 2025, against $4.66M in cash and short-term investments. Its debt-to-equity ratio was 0.15. Total debt was $1.45M a year earlier.

What are Longeveron's total assets?

Longeveron reported total assets of $10.26M as of Dec 31, 2025, down 59.9% from $25.56M a year earlier. Total liabilities were $4.59M.

What is Longeveron's shareholders' equity?

Longeveron's shareholders' equity was $5.67M as of Dec 31, 2025, or about $2.47 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition